EDE approves MIMRYLO for polycythemia vera, UAE becomes 2nd global market
The UAE cleared rusfertide for adults with polycythemia vera. Clinics and insurers now need a pathway for eligibility, monitoring and reimbursement.
2 Oct 2026 · 3 min read
Topic
takeda
1 articles